Publicaciones en colaboración con investigadores/as de Universidade de Vigo (19)

2024

  1. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

  2. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

    Nutrients, Vol. 15, Núm. 14

  2. MiRNA Differences Related to Treatment-Resistant Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  3. Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery

    Analytical Methods, Vol. 15, Núm. 37, pp. 4905-4917

2022

  1. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1921-1932

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  2. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 125-138

  3. The role of the second extracellular loop of norepinephrine transporter, neurotrophin-3 and tropomyosin receptor kinase C in T cells: A peripheral biomarker in the etiology of schizophrenia

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

2020

  1. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

    Frontiers in Psychiatry, Vol. 11

  2. Brainwaves Oscillations as a Potential Biomarker for Major Depression Disorder Risk

    Clinical EEG and Neuroscience, Vol. 51, Núm. 1, pp. 3-9

  3. Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways

    Frontiers in Psychiatry, Vol. 10

2018

  1. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship

    Schizophrenia Research, Vol. 197, pp. 19-33

  2. Serotonin syndrome versus neuroleptic malignant syndrome: a case report

    Actas Espanolas de Psiquiatria

2009

  1. Management of patients presenting with acute psychotic episodes of schizophrenia

    CNS Drugs, Vol. 23, Núm. 3, pp. 193-212

2007

  1. An analysis of the cognitive deficit of schizophrenia based on the Piaget developmental theory

    Comprehensive Psychiatry, Vol. 48, Núm. 4, pp. 376-379

2005

  1. Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, Núm. 6, pp. 972-982

2001

  1. Déficit cognitive y esquizofrenia

    Actas Espanolas de Psiquiatria, Vol. 29, Núm. 1, pp. 1-9